M46.80
Other specified inflammatory spondylopathies, site unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Other specified inflammatory spondylopathies (ICD-10 Code M46.80) refer to a group of inflammatory disorders affecting the spine, which are not classified under more common types of spinal spondylopathies. These conditions involve inflammation of the vertebral joints and surrounding tissues, leading to pain, stiffness, and potential mobility issues. Since the exact site of inflammation is unspecified, diagnosis and management require careful clinical evaluation, imaging studies, and sometimes laboratory tests. Recognizing these conditions is critical for effective treatment and improving quality of life.
Causes & Symptoms
Clinical Causes: Autoimmune responses, where the body's immune system mistakenly targets spinal tissues Infections affecting the vertebral joints (though less common) Genetic predispositions influencing immune regulation Chronic inflammatory diseases, such as psoriasis or inflammatory bowel disease, which may involve the spine Environmental factors, such as trauma or exposure to certain pathogens
Key Symptoms: Persistent back pain that worsens with activity or at certain times of day Stiffness in the spine, often more noticeable in the morning or after periods of inactivity Limited range of motion in affected areas Swelling or tenderness over spinal joints Possible radiating pain into limbs if nerve roots are involved Fatigue and general feelings of illness in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing other specified inflammatory spondylopathies involves a combination of clinical assessments and diagnostic tests. Healthcare providers typically conduct a thorough medical history and physical examination, focusing on symptoms and any associated autoimmune conditions. Imaging studies like X-rays, MRI, or CT scans are used to visualize inflammation, joint erosion, or structural changes in the spine. Laboratory tests may include blood work to identify markers of inflammation (e.g., ESR, CRP) or specific antibodies linked to autoimmune diseases. Sometimes, biopsy of spinal tissue may be necessary to exclude infections or malignancies.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to decrease inflammation and pain Disease-modifying antirheumatic drugs (DMARDs) or biologic agents for autoimmune components Physical therapy to improve flexibility, strengthen supporting muscles, and maintain mobility Regular exercise tailored to individual capacity Postural training and ergonomic adjustments In severe cases, surgical intervention might be considered to correct deformities or decompress nerve structures Monitoring and managing comorbid conditions, such as uveitis, cardiovascular issues, or gastrointestinal problems
Clinical Advice & FAQs
Billing Guidance
Is M46.80 a billable ICD-10 code?
Yes, M46.80 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M46.80?
Clinical documentation must specify the nature of Other specified inflammatory spondylopathies, site unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference